Tests nutrition education groups added to usual care for type 2 diabetes
Tests nutrition education groups alongside usual care in adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Effect of Nutrition Education Groups in the Treatment of Patients with Type 2 Diabetes
Key facts
- Where
- Porto Alegre, BrazilSee the 2 sites
Where in Brazil
- Hospital de Clinicas de Porto AlegrePorto Alegre, BrazilTaking people
- Universidade Federal do Rio Grande do SulPorto Alegre, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Hospital de Clinicas de Porto Alegre
- Trial code
- NCT05598203
- Record updated
- 18 March 2025
- Original description
Every year there is an increase in people with diabetes all over the world. Because it is a disease associated with several comorbidities and is increasing, there is a need for more effective treatments. Lifestyle changes combined with medication are the best strategies for the treatment and reduction of comorbidities. Therefore, the present study posits the hypothesis that the integration of nutritional education groups into standard treatment, within a nutrition-specialized outpatient clinic, may yield additional enhancements in health parameters among patients diagnosed with type 2 diabetes. The driving force behind this research lies in the pursuit of more effective strategies to enhance glycemic control, diminish the risk of complications, and elevate the overall quality of life for these patients. Our motivation stems from a commitment to base our interventions on scientific evidence and strive towards meaningful improvements in diabetes management outcomes. A randomized clinical trial will be conducted with adult patients with a previous diagnosis of type 2 diabetes. Patients will be divided into two groups (intervention: nutritional education added the usual care; and control: usual care). The outcomes analyzed will be: glycemic control, lipid profile, body mass and dynapenia obesity, blood pressure values, eating behavior, diabetes complications and adherence to recommendations.Read full original descriptionShow less
Effect of Nutritional Education Groups Added in the Usual Care of Outpatients with Type 2 Diabetes: a Randomized Clinical Trial
Every year there is an increase in people with diabetes all over the world. Because it is a disease associated with several comorbidities and is increasing, there is a need for more effective treatments. Lifestyle changes combined with medication are the best strategies for the treatment and reduction of comorbidities. Therefore, the present study posits the hypothesis that the integration of nutritional education groups into standard treatment, within a nutrition-specialized outpatient clinic, may yield additional enhancements in health parameters among patients diagnosed with type 2 diabetes. The driving force behind this research lies in the pursuit of more effective strategies to enhance glycemic control, diminish the risk of complications, and elevate the overall quality of life for these patients. Our motivation stems from a commitment to base our interventions on scientific evidence and strive towards meaningful improvements in diabetes management outcomes. A randomized clinical trial will be conducted with adult patients with a previous diagnosis of type 2 diabetes. Patients will be divided into two groups (intervention: nutritional education added the usual care; and control: usual care). The outcomes analyzed will be: glycemic control, lipid profile, body mass and dynapenia obesity, blood pressure values, eating behavior, diabetes complications and adherence to recommendations.
Inclusion: Adult patients with a previous diagnosis of type 2 diabetes mellitus.
Exclusion: Patients with other types of diabetes; Chronic kidney disease [glomerular filtration rate <30mL/min/1.73m²]; Autoimmune disease or chronic steroid use; Patients who have had an Episode of Acute Coronary Syndrome (ACS) in the last 60 days; Cognitive, neurological or psychiatric condition; With HbA1C within the therapeutic target or with values greater than 12%; Severe neuropathy; Life expectancy <6 months; Chemical dependence/alcoholism or use of antipsychotics; Gastroparesis; Pregnant or lactating women; Wheelchair users.